These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 34436155)
1. Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis. Prakash H; Skiada A; Paul RA; Chakrabarti A; Rudramurthy SM J Fungi (Basel); 2021 Jul; 7(8):. PubMed ID: 34436155 [TBL] [Abstract][Full Text] [Related]
2. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease. Rao C; R M J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why. Radotra B; Challa S Curr Fungal Infect Rep; 2022; 16(4):206-220. PubMed ID: 36193101 [TBL] [Abstract][Full Text] [Related]
4. Mucormycosis in 2023: an update on pathogenesis and management. Alqarihi A; Kontoyiannis DP; Ibrahim AS Front Cell Infect Microbiol; 2023; 13():1254919. PubMed ID: 37808914 [TBL] [Abstract][Full Text] [Related]
5. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis. Alqarihi A; Gebremariam T; Gu Y; Swidergall M; Alkhazraji S; Soliman SSM; Bruno VM; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS mBio; 2020 Jun; 11(3):. PubMed ID: 32487760 [TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease (COVID-19)-associated mucormycosis (CAM): The unholy triad of COVID-19, diabetes mellitus, and corticosteroid therapy. Juyal D; Pal S; Negi N; Singh M; Kumar M; Singhal S J Family Med Prim Care; 2023 Nov; 12(11):2538-2541. PubMed ID: 38186842 [TBL] [Abstract][Full Text] [Related]
8. Multimodal analysis of the COVID-19-associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors. Chowdhary A; Gupta N; Wurster S; Kumar R; Mohabir JT; Tatavarthy S; Mittal V; Rani P; Barman P; Sachdeva N; Singh A; Sharma B; Jiang Y; Cuomo CA; Kontoyiannis DP Mycoses; 2023 Jun; 66(6):515-526. PubMed ID: 36790120 [TBL] [Abstract][Full Text] [Related]
9. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. Liu M; Spellberg B; Phan QT; Fu Y; Fu Y; Lee AS; Edwards JE; Filler SG; Ibrahim AS J Clin Invest; 2010 Jun; 120(6):1914-24. PubMed ID: 20484814 [TBL] [Abstract][Full Text] [Related]
10. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Rudramurthy SM; Hoenigl M; Meis JF; Cornely OA; Muthu V; Gangneux JP; Perfect J; Chakrabarti A; Mycoses; 2021 Sep; 64(9):1028-1037. PubMed ID: 34133816 [TBL] [Abstract][Full Text] [Related]
11. Mucormycosis, past and present: a comprehensive review. Gupta I; Baranwal P; Singh G; Gupta V Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World. Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555 [TBL] [Abstract][Full Text] [Related]
13. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis. Ibrahim AS Mycoses; 2014 Dec; 57 Suppl 3(0 3):13-7. PubMed ID: 25178879 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran. Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164 [TBL] [Abstract][Full Text] [Related]
16. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus. Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for COVID-19 associated mucormycosis in India: A case control study. Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394 [TBL] [Abstract][Full Text] [Related]
18. CotH3 mediates fungal invasion of host cells during mucormycosis. Gebremariam T; Liu M; Luo G; Bruno V; Phan QT; Waring AJ; Edwards JE; Filler SG; Yeaman MR; Ibrahim AS J Clin Invest; 2014 Jan; 124(1):237-50. PubMed ID: 24355926 [TBL] [Abstract][Full Text] [Related]
19. Mucormycosis in the COVID-19 Environment: A Multifaceted Complication. Sharma R; Kumar P; Rauf A; Chaudhary A; Prajapati PK; Emran TB; Gonçalves Lima CM; Conte-Junior CA Front Cell Infect Microbiol; 2022; 12():937481. PubMed ID: 35923801 [TBL] [Abstract][Full Text] [Related]
20. Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review. Sharma B; Nonzom S Curr Microbiol; 2023 Aug; 80(10):322. PubMed ID: 37592083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]